Advisor Group Holdings, Inc. Nemaura Medical Inc. Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.32 - $1.14 $160 - $570	500 New	500 $0
Q3 2022 Nov 14, 2022	SELL	$1.52 - $2.57 $304 - $514	-200 Reduced 80.0%	50 $0
Q1 2022 May 04, 2022	BUY	$3.78 - $4.66 $189 - $233	50 Added 25.0%	250 $1,000
Q3 2021 Nov 05, 2021	BUY	$5.76 - $9.95 $1,152 - $1,989	200 New	200 $1,000
Q4 2020 Feb 10, 2021	SELL	$3.47 - $4.52 $5,205 - $6,779	-1,500 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$3.55 - $9.99 $3,550 - $9,990	1,000 Added 200.0%	1,500 $5,000
Q2 2020 Aug 14, 2020	BUY	$4.75 - $15.38 $2,375 - $7,690	500 New	500 $5,000

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.